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Receptor-linked class I phosphoinositide 3-kinases (PI3Ks) induce assembly of signal transduction complexes through
protein–protein and protein–lipid interactions that mediate cell proliferation, survival, and migration. Although class II
PI3Ks have the potential to make the same phosphoinositides as class I PI3Ks, their precise cellular role is currently
unclear. In this report, we demonstrate that class II phosphoinositide 3-kinase C2 (PI3KC2) associates with the
Eps8/Abi1/Sos1 complex and is recruited to the EGF receptor as part of a multiprotein signaling complex also involving
Shc and Grb2. Increased expression of PI3KC2 stimulated Rac activity in A-431 epidermoid carcinoma cells, resulting in
enhanced membrane ruffling and migration speed of the cells. Conversely, expression of dominant negative PI3KC2
reduced Rac activity, membrane ruffling, and cell migration. Moreover, PI3KC2-overexpressing cells were protected from
anoikis and displayed enhanced proliferation, independently of Rac function. Taken together, these findings suggest that
PI3KC2 regulates the migration and survival of human tumor cells by distinct molecular mechanisms.
INTRODUCTION
Phosphoinositide 3-kinases (PI3Ks) trigger activation of sig-
naling pathways in response to extracellular stimuli that
regulate diverse cellular programs such as cell survival,
proliferation and migration, phagocytosis, and glucose ho-
meostasis (Katso et al., 2001). There are three classes of PI3Ks
in mammals. Class I PI3Ks primarily generate PI(3,4,5)P3,
which binds to pleckstrin homology (PH) domains and ac-
tivates a variety of proteins including the serine/threonine
kinase PKB/Akt and exchange factors for small GTPases.
Class II PI3Ks have the potential to generate PI(3,4,5)P3, but
the type of PIPs that they produce in vivo has not been fully
characterized. The sole class III PI3K, Vps34, produces
PI(3)P. Class I PI3Ks and 3-phosphosphorylated phosphati-
dylinsitols (PIs) have been implicated in cancer: the phos-
phatase PTEN removes the 3-phosphate from 3-phosphory-
lated inositides generated by PI3Ks, and PTEN is a tumor
suppressor gene mutated in a variety of human cancers
(Yamada and Araki, 2001). In addition, mutation, amplica-
tion and/or overexpression of some PI3K class I catalytic
subunits has been found is some cancers (Katso et al., 2001;
Vogelstein and Kinzler, 2004).
Although the class I PI3K family has been implicated in
multiple cellular processes (Katso et al., 2001; Vanhaesebroeck
et al., 2001), much less is known about the function of the
class II PI3K enzymes, PI3KC2, PI3KC2, and PI3KC2.
Both PI3KC2 and PI3KC2 have been implicated in signal-
ing by tyrosine kinase receptors. They are recruited to a
signaling complex including the EGF receptor after EGF
activation of A-431 cells (Arcaro et al., 2000) and to the stem
cell factor (SCF) receptor in small lung cell carcinoma cell
lines (Arcaro et al., 2002). The interaction of PI3KC2 with
the EGF receptor requires the adaptor protein Grb2, and the
SH3 domains of Grb2 bind directly to three proline-rich
regions near the amino terminus of PI3KC2 (Wheeler and
Domin, 2001). Interestingly, PI3KC2 is required together
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with class IA PI3Ks for activation of Akt by SCF (Arcaro et
al., 2002).
To investigate signaling by PI3KC2, we sought to iden-
tify its interacting partners. We identified Eps8 as a tyrosine-
phosphorylated protein associated with PI3KC2 and estab-
lished that PI3KC2 is part of a multiprotein signaling
complex including Grb2, Eps8, Abi1, and Sos that is assem-
bled and recruited to the EGF receptor, after EGF stimula-
tion. PI3KC2 regulated Rac activity and c-Jun N-terminal
kinase (JNK) activation, consistent with the role of the Eps8-
Abi1-Sos complex as an exchange factor for Rac. As a result,
PI3KC2 expression enhanced membrane ruffling and cell
motility. Moreover, PI3KC2-expressing cells displayed re-
duced sensitivity to detachment-induced apoptosis and in-
creased proliferation, which involved a Rac-independent
signaling pathway.
MATERIALS AND METHODS
Antibodies and Reagents
The following antibodies were used: Akt, Sos1, 9E10 myc epitope, and phos-
pho-Erk (Santa Cruz Biotechnology, Santa Cruz, CA), phosphor-Akt (Ser473),
Jun, phospho-Jun, JNK, and phospho-JNK (New England Biolabs, Beverly,
MA), Grb2 monoclonal and polyclonal, Shc, Eps8, E-cadherin and pan-Erk
antibodies (Transduction Laboratories, Lexington, KY), Rac, and 4G10 anti-
phosphotyrosine (Upstate Biotechnology, Lake Placid, NY), E-cadherin
monoclonal antibody (mAb; Zymed Laboratories, South San Francisco, CA).
The rabbit antibody to Abi1 was a kind gift from Paolo Di Fiore (European
Institute of Oncology, Milan, Italy). Recombinant human EGF was purchased
from R&D Systems (Minneapolis, MN). TRITC-conjugated phalloidin was
obtained from Sigma-Aldrich (St. Louis, MO). The Akt inhibitor (1L-6-
hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate), the
JNK inhibitor I, PD098059, and SB202190 were purchased from Calbiochem
(La Jolla, CA).
Cell Lines
A-431 cell lines stably expressing PI3KC2 WT and DN were generated as
previously described (Arcaro et al., 2000). The A-431 human epidermoid
carcinoma cells were maintained at 37°C, 10% CO2 under humidified condi-
tions in DMEM supplemented with 10% fetal bovine serum (FBS), penicillin-
streptomycin, and glutamine. The stock cell cultures were passaged every 4 d.
Cells were made quiescent by switching them to DMEM supplemented with
0.1% fetal calf serum (FCS) for 24 h. HEK 293 cells were maintained in
DMEM/10% FCS.
Immunoprecipitation and Immunoblotting Analysis
Cells were grown to 80% confluence in 10-cm dishes and starved for 24 h in
DMEM supplemented with 0.1% FCS. Where indicated, cells were then
stimulated with 1 nM EGF (6 ng/ml) for the indicated time periods. The cells
were washed once with ice cold phosphate-buffered saline (PBS) before lysis
on ice for 30 min in 1.00 ml of lysis buffer (1% Triton X-100, 0.5% NP-40, 150
mM NaCl, 50 mM Tris.HCl, pH 7.4, 1 mM EDTA, 0.5 mM EGTA) supple-
mented with protease inhibitors (10 g/ml aprotinin, leupeptin, pepstatin A,
trypsin, and 100 g/ml phenylmethylsulfonyl fluoride) and phosphatase
inhibitors (Sigma phosphatase cocktail I and II solutions). Insoluble material
was removed by centrifugation for 30 min (15,000 rpm at 4°C). The Triton-
insoluble fraction was analyzed by reextraction of the pellet from above in
RIPA lysis buffer (1% Triton X-100, 50 mM Tris.Cl, pH 7.4, 150 mM NaCl, 1
mM EDTA, 1% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovana-
date, 25 mM sodium fluoride, supplemented with 100 mg/ml AEBSF, and 5
mg/ml each of leupeptin, pepstatin A, and aprotinin). The lysates were
equalized for protein content before being immunoprecipitated. The total
protein concentration was measured using the calorimetric BCA protein assay
(Pierce, Rockford, IL). Protein, 800 g, was incubated with the respective
antibodies preadsorbed onto 50 l of protein A or G agarose beads. After 4-h
incubation at 4°C, the immune-complexes were washed three times in ice-
cold cell lysis buffer supplemented with 500 mM NaCl and protease inhibi-
tors. The immune-complexes were eluted and denatured by boiling for 5 min
in SDS sample buffer (50 mM Tris.HCl, pH 6.8, 2% SDS, 10% glycerol, 5%
-mercaptoethanol, and 0.25% bromophenol blue). For analysis of total cell
lysates, 40 g of total protein was resolved on 20-cm Hoeffer SDS-PAGE gels
(8–12%) and transferred to PVDF membranes in a Tris-glycine-methanol
buffer (190 mM glycine, 20% methanol, 25 mM Tris.HCl, pH 7.4) at 150 mA
per gel for 7 h at room temperature. After the transfer, blots were processed
with the respective antibodies using standard immunoblotting procedures.
Peptide Coupling and Affinity Purification
Peptides were purified by high-pressure liquid chromatography and lyoph-
ilized (Alta Bioscience, Birmingham, United Kingdom). The epidermal
growth factor receptor (EGFR) peptides and their phosphorylated (p) deriv-
atives corresponding to the EGFR pY992 Shc (DDVVDADEYLIP/DDV-
VDADEpYLIP) and pY1068 Grb2 (DTFLPVPEYINQ/DTFLPVPEpYING) Src
homology 2 (SH2) docking sites were used in the peptide pulldown experi-
ments. The PI3KC2 N-terminal proline-rich peptides, proline-rich peptide
(PR) 1 SPPPLPPRAS, PR2 WDTPPLPPRK, and PR3 MPPQVPPRTY were used
to map the putative Grb2 SH3-binding site. The lyophilized peptides were
resuspended in a sodium phosphate buffer solution (0.1 M sodium phosphate,
150 mM NaCl, pH 7.4, solution). Peptides were immobilized to Actigel-ALD
resin (Sterogene Bioseparations, Arcadia, CA) according to manufacturer’s
instructions. Aliquots of coupled peptides were stored at 4°C in the sodium
phosphate buffer supplemented with phosphatase inhibitors and 0.01% so-
dium azide. For the peptide pulldowns, 1 g of coupled peptide was incu-
bated with 800 g of protein at 4°C on a rotating wheel for 1 h. The peptides
were washed four times in lysis buffer before subjecting the complexes to
SDS-PAGE and immunoblot analysis.
Production of GST-Fusion Proteins
pGEX-2T expression vectors encoding PI3KC2 N-terminal (amino acids
1–300) domain, N-terminal Grb2 SH3 domain, C-terminal Grb2 SH3 domain,
Abi1 SH3 domain, Raf Ras-binding domain, and PAK CRIB domain were
transformed into Escherichia coli BL21 cells. GST fusion protein expression was
induced by adding 1 mM IPTG to a 1-l culture of exponentially growing cells
at 30°C for 4 h. The bacterial cells were harvested by centrifugation and were
either immediately processed or frozen down as bacterial pellets at 70°C.
The bacterial pellets were lysed at 4°C in 50 mM Tris.Cl, pH 8.0, 2 mM MgCl2,
10% glycerol, 20% sucrose, 2 mM DTT, 100 g/ml AEBSF, 1 g/ml each of
aprotinin, leupeptin, and pepstatin A. GST fusion proteins were affinity-
purified by incubating the clarified lysate with glutathione Sepharose beads
(Pharmacia Biotech, St Albans, United Kingdom) at 4°C on a rotating wheel
for 1 h. After extensive washing of the Sepharose beads, bound proteins were
eluted by incubating the glutathione Sepharose with 10 mM reduced gluta-
thione in 50 mM Tris.Cl, pH 8.0. The eluted proteins were dialyzed with 100
mM Tris.HCl, pH 7.4, 150 mM NaCl and stored in aliquots in a buffer made
up of 20% glycerol, 100 mM Tris.Cl, pH 7.4, and 150 mM NaCl at 70°C.
Rac Activity Assays
A glutathione S-transferase (GST)-PAK Cdc42 and Rac-binding region (CRIB)
fusion protein was incubated with cell lysates to pull down GTP-bound active
Rac. GST-PAK CRIB fusion protein was prepared just before the pulldown
assays. (This is all in the section above.) The Sepharose beads with bound
GST-PAK CRIB were washed three times in lysis buffer and once in Rac
pulldown buffer (50 mM Tris.HCl, pH 7.4, 12 mM MgCl2, 10% glycerol, 100
mM NaCl, 1% NP-40, 50 mM NaF, 1 mM sodium orthovanadate, 1 g/ml
pepstatin, 1 g/ml aprotinin, 1 g/ml leupeptin, and 100 g/ml AEBSF). The
Sepharose beads were aliquoted (25 l) into individual tubes for the Rac
pulldown assay. Alternatively, GST-PAK CRIB beads were purchased from
Upstate Biotechnology. A-431 cells were grown to 80% confluence and made
quiescent by culturing them in serum-free medium (0.1%) for 24 h. The cell
culture plates were immediately placed on ice, washed once with ice-cold
PBS, and lysed for 5 min on ice with 1 ml Rac pulldown buffer (this is given
above). The lysates were clarified by centrifugation (14,000  g, 4°C, 5 min),
and protein concentration was determined (Bradford assay, Pierce). Equal
amounts of lysates were incubated with GST-PAK CRIB fusion protein at 4°C
for 30 min. The beads were washed three times in lysis buffer and eluted in
Laemmli sample buffer. The amount of Rac pulled down was determined by
immunoblotting with anti-Rac mAb (Upstate Biotechnology).
PI3K Assays
For the immune-complex kinase assays, cells were lysed in RIPA buffer for 30
min on ice. The cell lysates were clarified by centrifugation (14,000  g, 4°C,
15 min), and aliquots were taken from the respective tubes for protein
quantification. Equal amounts of lysates were incubated with the respective
antibodies for 4 h at 4°C. The immune-complexes were washed three times in
lysis buffer, once in 50 mM HEPES, pH 7.5, and once in 2 PI3K assay buffer
(40 mM Tris.HCl, pH 7.4, 200 mM NaCl). The PI3K assay was initiated by
resuspending the immune-complexes in 25 l of 2 PI3K assay buffer. The
phospholipids (PI, PI(4)P, and PI(4,5)P2) were sonicated for 10 min and added
at a final concentration of 0.2 mg/ml to the sample tubes. The tubes were
incubated on ice for 20 min to allow the substrate to bind to the enzyme.
Fifteen microliters of the assay reaction mix (40 mM ATP, 3.5 mM divalent
cation, and 10 Ci [-32P]ATP) were added to each of the sample tubes on ice
before transferring them to room temperature for 20 min. The reactions were
terminated by placing the tubes on ice and adding 100 l of 1 M HCl in
addition to 200 l of a 1:1 solution of chloroform and methanol. The samples
were vortexed and centrifuged for 2 min at room temperature. The organic
phase was collected and extracted with 80 l of a 1:1 solution of methanol and
1 M HCl. The tubes were vortexed and centrifuged for 2 min at room
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temperature, and the organic phase containing the lipids was transferred to a
fresh tube. The lipids were dried down in a speed vacuum before determining
the amount of radioactivity incorporated by Cerenkov counting. The lipids
were resuspended in 30 l of a 4:1 solution of chloroform and methanol and
spotted onto channeled Silica Gel 60 TLC plates (Whatman, Clifton, NJ) that
had been pretreated in 1% oxalic acid, 1 mM EDTA, 40% methanol and baked
for 15 min at 110°C. The TLC plates were developed in propan-1-ol, 2 M acetic
acid (65:35) for 4 h, and the radiolabeled spots were quantified using a
PhosphoImager (Molecular Dynamics, Sunnyvale, CA).
Immunofluorescence and Localization of F-Actin
A-431 cells (1  104) were seeded on glass coverslips and grown for 48 h.
Coverslips were rinsed in PBS and fixed for 10 min in 4% (wt/vol) parafor-
maldehyde at room temperature. Cells were permeabilized in a solution of
0.2% Triton X-100 for 5 min and then rinsed with PBS. The coverslips were
then incubated with either mouse anti-myc epitope (9E10) or anti-E-cadherin
antibodies followed by FITC-labeled goat anti-mouse antibodies and TRITC-
conjugated phalloidin for 30 min. Coverslips were mounted in Moviol (Cal-
biochem, San Diego, CA). Cells were examined by confocal laser scanning
microscopy (LSM 510; Zeiss, Welwyn Garden City, United Kingdom). Image
files were collected as a matrix of 1024  1024 pixels describing the average
of eight frames scanned at 0.062 Hz.
Transfections
Control and PI3KC2-transfected A-431 cells were plated on gelatin-coated
13-mm glass coverslips. Cells were transfected with HA-RacN17 or the ap-
propriate empty vector using Fugene 6 (Roche, Lewes, East Sussex, United
Kingdom), according to manufacturer’s instruction. After 8 h, cells were
serum starved in 0.5% FBS overnight, and treated with EGF (100 ng/ml) for
10 min or were mock-treated. Cells were then fixed with 4% paraformalde-
hyde, permeabilized with 0.1% Triton X-100, and blocked in 1% BSA. Immu-
nostaining was performed with the indicated antibodies. FITC-conjugated
goat anti-mouse IgGs were used as secondary antibodies. Each experiment
was performed at least there time with similar results.
Time-Lapse Video
Control and PI3KC2-transfected A-431 cells were plated on 100-mm plates in
DMEM containing 10% FBS. For live imaging, cells were analyzed with an
Olympus IX-70 (Lake Success, NY), collecting images every 30 s for up to 30
min. Images were compiled into movies by using the program Metamorph.
Cell Proliferation
A-431 cell lines (105/ml) were grown for 3 d in serum-containing medium
(1 or 10%) in the presence or absence of inhibitors. Cell proliferation was
analyzed by MTS assay using the CellTiter 96 Aqueous One Solution Cell
Proliferation Assay (Promega, Madison, WI).
Induction of Cell Death by Anoikis
Cells grown in attachment were trypsinized and washed once in E4/10% FCS.
The cells were then placed in Ultralow attachment plates (Corning; rehy-
drated according to manufacturer’s instruction) at 1  106 cells in 3 ml of E4
medium containing 10% FCS and left for 6, 12, or 24 h at 37°C/10% CO2 in the
presence or absence of 50 M PD098059 or 10 M SB202190.
Sub-G1 Determination by Flow Cytometry
In E4 medium, 1 106 cells containing 10% FCS were centrifuged at 1000 rpm
for 5 min and then washed once in PBS before fixation in ice-cold 70% ethanol
for 30 min at 4°C. Cells were then washed twice in phosphate-citrate buffer
(198 parts of 0.2 M Na2HPO4 and 8 parts of 0.1 M citric acid, pH 7.8), and the
pellet was resuspended in 50 l of 100 g/ml RNAse for 10 min. DNA
content was then determined by flow cytometry after addition of 200 l of 50
g/ml propidium iodide (Molecular Probes, Eugene, OR).
Annexin V/Propidium Iodide Flow Cytometry Analysis
Cells were resuspended at 1  106 cells/ml in binding buffer (10 mM HEPES,
pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). This suspension, 100 l, was mixed
with 5 l of fluorescein isothiocyanate-conjugated annexin V reagent (Molec-
ular Probes) and 10 l of propidium iodide solution (Molecular Probes). The
samples were left for 15 min at room temperature in the dark before the
addition of a further 400 l of binding buffer. The samples were analyzed by
flow cytometry.
Protein Down-Regulation by RNAi Oligonucleotides
All oligonucleotides were purchased from Dharmacon (Boulder, CO) and
used at 70 nM. Cells at 50% confluence were transfected using the Oligo-
fectamine transfection reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. Cells were then incubated at 37°C/10% CO2 for
48 h to allow for target down-regulation. The efficiency of protein down-
regulation was assessed by SDS-PAGE and Western blotting.
E-Cadherin Neutralization
In a normal or ultralow attachment 96-well plates (Corning Glass, Corning,
NY), 104 cells per well were treated for 12 or 24 h with 20 g/ml E-cadherin
antibody (clone HECD-1, Zymed, South San Francisco, CA) in E4 medium
containing 10% FCS. Cells were either analyzed for sub-G1 by flow cytometry
or stained for actin using AlexaFluor 488-Phalloidin (Molecular Probes) ac-
cording to manufacturer’s instructions.
Cell Motility Assays
Cells plated at 25% confluence in 24 well-plates were imaged by phase
contrast using a motorized-staged environment controlled Zeiss microscope.
Time-lapse images (1 image/10 min/well for 18 h) were acquired using a
prior camera linked to the AQM Advance 6 Software (Kinetic Imaging,
Liverpool, United Kingdom). Each condition was performed in quadrupli-
cate. Fifteen cells were tracked per replicate using a Kinetic Imaging plug-in
and tracks analyzed by Mathematica 5 (Wolfram Research, Champaign, IL)
for migration speed and persistence distribution.
RESULTS
PI3KC2 Is Associated with Shc and Grb2
To investigate signaling partners of PI3KC2, we sought to
identify PI3KC2 binding proteins. We have previously
shown that PI3KC2 associates with a complex of tyrosine
phosphorylated proteins that include EGFR-1 in cells stim-
ulated with EGF (Arcaro et al., 2000). A-431 cells expressing
Myc-tagged wild-type PI3KC2 (A-431-C2 WT cells) were
stimulated with EGF and lysed, and anti-Myc immunopre-
cipitates from the Triton-soluble and -insoluble fractions
were analyzed for the presence of tyrosine-phosphorylated
proteins. In the Triton-soluble fraction, two tyrosine-phos-
phorylated proteins of about 50 kDa were identified by
immunoblotting as the p46/p52 Shc isoforms (Figure 1A). In
the immunoprecipitates from the Triton-insoluble fraction,
in addition to the p46/p52Shc isoforms, p66Shc was also
specifically tyrosine phosphorylated (Figure 1B).
Given that the PI3KC2 N-terminal proline-rich domain
mediates the interaction of PI3KC2 with Grb2 (Wheeler
and Domin, 2001), we tested whether this domain was also
responsible for PI3KC2 interaction with Shc. The N-termi-
nal 300 amino acids of PI3KC2 pulled down both Grb2 and
Shc (Figure 1, C and D). The interaction between the p66Shc
isoform and the PI3KC2 N-terminal region was constitu-
tive, whereas in the case of the p46/p52Shc isoforms it was
induced by EGF (Figure 1C). There was an apparent discrep-
ancy between the constitutive association of the PI3KC2
N-terminal region with p66Shc (Figure 1C) and the EGF-
stimulated interaction of PI3KC2 with Shc isoforms (Figure
1, B and G). A possible explanation for these differences may
be that the PI3KC2 N-terminal region is not accessible in
the full-length enzyme before EGF stimulation, whereas in
the pulldown experiments (Figure 1C) the recombinant N-
terminal region is free to associate with multiprotein com-
plexes involving p66Shc. Both the isolated N- and C-termi-
nal SH3 domains of Grb2 bound PI3KC2, but not PI3KC2
(Figure 1E), suggesting a Grb2-PI3KC2 isoform-specific in-
teraction. The PI3KC2 domain that binds to Grb2 was
mapped through peptide pulldown assays to two proline-rich
stretches encompassing proline region 1 (PR1) (SPPPLPPRAS),
and PR3 (MPPQVPPRT; Figure 1F). Interestingly, neither of
these proline-rich regions is present in the PI3KC2 and 
enzymes, implying that this association may be unique to
the  isoform. Coimmunoprecipitation analysis showed that
the association between Grb2 and PI3KC2 was constitutive,
whereas the interaction between the p46/p52Shc isoforms
and PI3KC2 was EGF-dependent (Figure 1G). These results
suggest that PI3KC2 is recruited to the EGFR-1 either in-
directly through Grb2 interaction with Shc or directly
through Grb2 interaction with the EGFR-1. Consistent with
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Figure 1. Identification of PI3KC2-binding proteins. (A) A-431-C2 WT cells were grown to 80% confluence and serum-starved for 24 h
before stimulation with EGF for the times indicated. The Triton X-100–soluble (A) and –insoluble fraction (B) were generated as outlined in
Materials and Methods. PI3KC2-associated proteins were identified by immunoblotting with the indicated antibodies. (C–E) Lysates from
parental A-431 cells were equalized for protein content before immunoprecipitation with the indicated GST-fusion proteins. PI3KC2
N-terminal 300 amino acid domain mediates recruitment of Shc and Grb2 (C and D). Gst-Grb2 pulldowns indicate selective recruitment of
PI3KC2 (E). (F) A-431 cell lysates were equalized for protein content before immunoprecipitations with the Actigel coupled PI3KC2
proline-rich peptides, PR1, PR2, and PR3. The amount of Grb2 precipitated by the respective peptides was determined by imuunoblotting.
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this hypothesis, EGFR-1 tyrosine-phosphorylated peptides
representing residues Y992 and Y1068, the Shc and Grb2
docking sites respectively, immunoprecipitated endogenous
PI3KC2 in vitro (Figure 1H).
These observations are in agreement with previous find-
ings that implicated pY992 and pY1068 and Grb2 in the
recruitment of PI3KC2 by EGFR-1 (Arcaro et al., 2000;
Wheeler and Domin, 2001).
Interaction of PI3KC2 and the Eps8-Abi1-Sos1 Complex
EGF induced a shift in PI3KC2 localization from the Triton-
soluble to the -insoluble fraction (Figure 1A, bottom, and B),
suggesting an increased association of PI3KC2 with the
cytoskeleton and/or signaling microdomains such as rafts.
A 98-kDa tyrosine-phosphorylated protein was detected in
PI3KC2 immunoprecipitates from the Triton-insoluble frac-
tion and was identified as Eps8 by immunoblotting (Figure
1B). Endogenous Eps8 coprecipitated with PI3KC2 from
A-431-C2 WT cells in the insoluble fraction (Figure 1B) and
the soluble fraction (Figure 2D). Eps8 has been implicated
in the coordination of EGF receptor signaling and trafficking
through regulation of Rac and Rab5, respectively, through
two mutually exclusive complexes: the Rac GEF ternary
complex, Eps8-Abi1-Sos1, and the Rab5-regulatory complex,
Eps8-RN-tre (Scita et al., 1999; Lanzetti et al., 2000). PI3KC2
immunoprecipitates prepared from the Triton-insoluble
fraction contained Sos-1 and Eps8 (Figure 2A), and Eps8
immunoprecipitates contained PI3KC2 and Abi1 (Figure
2B), indicating that PI3KC2 is complexed with the Eps8 Rac
GEF ternary complex (Figure 2B). A-431 cells normally ex-
press low but detectable levels of PI3KC2 (Arcaro et al.,
2000). Because of the low levels of endogenous PI3KC2, we
were unable to detect the complex in A-431 cells, but we did
detect an association of endogenous Eps8 and PI3KC2 in
HEK 293 cells, demonstrating that this is a physiological
relevant complex (Figure 2C). In contrast, no association
between PI3KC2 and Eps8 was observed in HEK 293 cells.
Control immunoprecipitations were also performed, which
revealed the specificity of the association of Grb2, Shc, Eps8,
and Sos-1 with PI3KC2 in A-431-C2 WT cells (Figure 2D).
In the Triton-soluble fraction, PI3KC2 was constitutively
associated with Grb2, and EGF stimulation promoted the
interaction of the enzyme with the activated EGFR, Shc,
Eps8, and Sos-1 (Figures 1A and 2D). In contrast, in the
Triton-insoluble fraction, PI3KC2 was constitutively asso-
ciated with the activated EGFR, Grb2, Eps8, and Sos-1 (Fig-
ures 1B, 2, A and B, and 3A). The constitutive association of
the complex in the Triton-insoluble fraction was possibly
caused by basal activation of the EGFR, either by autocrine
TGF- production, or overexpression of the receptor in
A-431 cells (Van de Vijver et al., 1991; Jo et al., 2000).
To identify the domains of PI3KC2 and Eps8 involved in
the formation of the complex in A-431 cells, we used pull-
down assays with immobilized recombinant GST-domains.
The N-terminal region of PI3KC2 interacted with Eps8 in
A-431 lysates, independently of EGF stimulation, but no
interaction was observed between the PI3KC2 C2 domain
and Eps8 (Figure 2E). This data correlated with the obser-
vation that this region of PI3KC2 interacts with Shc and
Grb2 (Figure 1C). The N-terminal region of Eps8 (residues
1–535) and its SH3 domain both interacted with PI3KC2 in
lysates from unstimulated A-431-C2 WT cells (Figure 2F).
However, the Eps8 PTB domain failed to bind to PI3KC2 in
a comparable manner (Figure 2F). Thus, multiple surfaces of
interaction are likely to participate in the formation of an
Eps8-PI3KC2 complex.
Assembly of the Grb2-PI3KC2-Eps8-Abi1-Sos1
Multiprotein Complex
To establish whether the Shc/Grb2/PI3KC2 and the
PI3KC2/Eps8/Abi1/Sos1 complexes were mutually exclu-
sive complexes or one macromolecular complex, we investi-
gated whether Grb2 could coimmunoprecipitate with Eps8.
Grb2 immunoprecipitates from the Triton-insoluble fraction
of A-431-C2 WT cells contained PI3KC2 and Eps8 as well
as Sos1 (Figure 3A). Interaction mapping of the Eps8-Abi1-
Sos1 Rac GEF ternary complex has shown that Abi1 acts as
a scaffold protein, which holds together Eps8 and Sos1 (Fan
and Goff, 2000; Scita et al., 2000). More specifically, the
ternary complex is assembled through binding of the Abi1
and Eps8 SH3 domains to the proline rich motifs of Sos1 and
Abi1, respectively.
Profile motif scanning of Abi1 and Eps8 with a peptide
library–based searching algorithm (Yaffe et al., 2001) indi-
cated a putative proline-rich Grb2 binding site on Abi1
(NIADSPTPPPPPD). GST-Grb2 fusion protein pulldowns
demonstrated that Abi1 and Eps8 predominantly associated
with the N-terminal SH3 domain of Grb2 (Figure 3B). In addi-
tion, endogenous Abi1 coimmunoprecipitated with Grb2 (Fig-
ure 3C), consistent with the observed coimmunoprecipita-
tion of Abi1 and Grb2 in an independent study (Fan and
Goff, 2000). To determine the physiological relevance of this
complex, we investigated whether endogenously expressed
Grb2 associated with the Eps8/Abi1/Sos1 Rac GEF ternary
complex. Consistent with earlier findings (Fan and Goff,
2000), we observed coimmunoprecipitation of Abi1 with
endogenously expressed Grb2, Eps8, and Sos1, as well as
PI3KC2 (Figure 3D). Moreover, assembly of the Grb2-
PI3KC2-Eps8-Abi1-Sos1 complex was observed in two in-
dependent A-431 clones expressing kinase-dead PI3KC2
(A-431-C2 DN-17 and DN-32) implying that PI3KC2 lipid
kinase activity is not required for the assembly of this com-
plex (unpublished data).
These findings suggest that Grb2, Eps8, Abi1, Sos1, and
PI3KC2 can assemble into a single complex in A-431 cells
upon EGF stimulation (Supplementary Figure 3). We favor a
model whereby PI3KC2 is complexed with the Eps8-Abi1-
Sos1 ternary complex through direct binding of the N- and
C-terminal SH3 domains of Grb2 to Abi1 and PI3KC2,
respectively (Supplementary Figure 3). However, the possi-
bility that additional interactions occur in this multiprotein
complex cannot be ruled out. Analysis of PI3K kinase activ-
ity in the presence of calcium ions, which are inhibitory to
class I PI3Ks but can be utilized by class II enzymes (Arcaro
et al., 1998), indicated associated class II PI3K enzymatic
activity was in the Grb2, Shc, Eps8, and Abi1 immune-
complexes (Figure 3E). EGF stimulation did not stimulate
PI3KC2 activity in Grb2 immunoprecipitates (Figure 3E),
which was consistent with the constitutive association be-
tween the two proteins (Figures 1G and 2D). In contrast, a
marked increase in associated PI3KC2 kinase activity was
observed in Shc, Eps8, and Abi1 immunoprecipitates after
EGF stimulation, which probably reflects increased or stabi-
Figure 1 (cont). (G) The A-431-C2 WT cell line was induced with
1 nM EGF for the times indicated before immunoprecipitation with
Shc and Grb2. Analysis of the respective immune-complexes indi-
cates that Grb2 and the p46/p52Shc isoforms both associate with
PI3KC2. (H) A-431 cell lysates were immunoprecipitated with
Actigel coupled phosphorylated and nonphosphorylated peptides
representing the EGFR-1 SH2-binding peptides for Grb2 (pY1068/
Y1068) and Shc (pY992/992). The amount of endogenous PI3KC2
pulled down was determined by immunoblotting.
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lized association of PI3KC2 with the respective proteins
(Figures 1 and 2).
PI3KC2 Regulates Rac Activity, Epithelial Adherens
Junctions, and Membrane Ruffling
Targeted disruption of Eps8 results in a reduction in plate-
let-derived growth factor (PDGF)-induced membrane ruf-
fling, Rac activation, and consequently JNK activation in
fibroblasts (Scita et al., 1999). Eps8 interacts with Abi1 and
Sos to regulate the Rac GEF activity of Sos (Scita et al., 2001;
Innocenti et al., 2002, 2003). To establish whether PI3KC2
affected Rac activity, A-431 cells were transfected with either
Myc-tagged wild-type PI3KC2 (A-431-C2 WT) or a ki-
nase-dead PI3KC2 that was rendered catalytically inactive
by mutation of the highly conserved aspartate (DFG) to an
alanine residue in the activation domain (D1213A, DN). Lipid
immune-complex kinase assays of the respective Myc-tagged
PI3KC2 proteins demonstrated that PI3KC2 D1213A (DN)
was indeed catalytic inactive (Supplementary Figure 1A). The
Cdc42/Rac interactive binding region (CRIB) domain of PAK1
that binds specifically to active GTP-bound Rac (Sander et
al., 1998) was used to assess Rac1 activity in the A-431–
derived cell lines. In comparison to parental A-431 cells,
basal and EGF-stimulated Rac1 activities were significantly
Figure 2. PI3KC2 associates with the Eps8-
Abi1-Sos1 Rac GEF ternary complex. (A and
B) A-431-C2 WT cells were stimulated with
EGF for the indicated time points and then
lysed. The Triton X-100–insoluble fractions
were solubilized in RIPA buffer and then in-
cubated with antibodies to PI3KC2 (A) or
Eps8 (B). Immunoprecipitates were resolved
by SDS-PAGE and then Western blots were
probed with antibodies to Eps8 or Sos1 (A), or
PI3KC2, Eps8, Abi1, and Sos1. (C) Endoge-
nous PI3KC2 and Eps8 associate in HEK293
cells. Triton X-100–soluble lysates from serum-
starved () and EGF-induced () HEK293 cells
were immunoprecipitated with antibodies to
PI3KC2, PI3KC2, or control rabbit immuno-
globulin (IgG). Immunoprecipitates were re-
solved by SDS-PAGE and Western blotted
with antibodies to Eps8. (D) A-431-C2 WT
cells were stimulated with EGF for 10 min.
The Triton X-100–soluble fraction was immu-
noprecipitated with immobilized anti-Myc tag
or control (mouse IgG) antibodies. Associated
proteins were identified by immunoblotting
with the indicated antibodies. Cell lysate was
analyzed in parallel (20% of total lysate used
in the immunoprecipitations). (E) Lysates from
quiescent or EGF-stimulated A-431 cells were
incubated with immobilized GST, or GST-do-
mains corresponding to PI3KC2 N-terminal
region or C2 domain. The samples were ana-
lyzed by Western blot with anti-Eps8 antibod-
ies. (F) Lysates from A-431-C2 WT cells were
incubated with immobilized GST, or GST-do-
mains corresponding to Eps8 N-terminal re-
gion (residues 1–535) SH3, or PTB domain.
The samples were analyzed by Western blot
with anti-Myc tag antibodies.
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increased in A-431-C2 WT cells (Figure 4A). In contrast,
Rac1 activity was notably decreased in the A-431-C2 DN
cells (Figure 4A) implying that PI3KC2 lipid kinase activity
regulates Rac1. Consistent with this observation, EGF-stim-
ulated JNK1/2 activity and c-Jun phosphorylation were up-
regulated in A-431-C2 WT cells compared with wild-type
A-431 cells (Figures 4, B and C). Conversely, JNK1/2 activity
and c-Jun phosphorylation were decreased in the A-431-C2
DN cells (Figure 4, B and C). Basal and EGF-stimulated
activation of Erk1/2 were attenuated in either A-431-C2
WT or DN cells, as compared with wild-type A-431 cells
(Figure 4D). In contrast, activation of Akt1 was comparable
between A-431 and A-431-C2 WT cell lines, as assessed by
EGF-stimulated induction of Ser473 phosphorylation (Fig-
ure 4E). Thus PI3KC2 catalytic activity selectively regu-
lates Rac1 activation in response to EGF in A-431 cells,
which impacts on JNK1/2 activity and c-Jun phosphory-
lation. In contrast, PI3KC2 overexpression attenuates
Erk1/2 activation independently of its lipid kinase activ-
ity in A-431 cells.
Figure 3. Assembly of the Grb2-PI3KC2-
Eps8-Abi1-Sos multiprotein complex. (A) Grb2
was immunoprecipitated from Triton X-100–in-
soluble A-431-C2 WT cell lysates and probed
with the antibodies to Sos1, PI3KC2, Eps8, and
Grb2. (B) Abi1 interacts with Grb2. Lysates from
A-431 and A-431-C2 WT cell line were immu-
noprecipitated with either the N- or C-terminal
SH3 Gst-Grb2 fusion proteins. Precipitated pro-
teins from the respective lysates were immuno-
blotted with Abi1 and Eps8. (C) Abi1 and con-
trol rabbit Immune-globulin complexes from
Triton X-100–insoluble lysates of A-431 cells
were Western-blotted with anti-Abi1 and anti-
Grb2 antibodies. (D) A-431-C2 WT cells were
serum-starved for 24 h () and stimulated with
EGF for 5 min (). Cell lysates were immuno-
precipitated with antibodies to Myc, Grb2, Eps8,
Abi1, or Sos1 then Western blotted with anti-
bodies to Abi1. (E) Immune-complex class II
PI3K lipid kinase activity was evaluated in the
presence of calcium ions as previously de-
scribed (Arcaro et al., 1998). The results repre-
sent the mean of two independent experiments.
PI3KC2 Regulates Rac and Cell Migration
Vol. 17, September 2006 3735
Figure 4. PI3KC2 regulates Rac and JNK activity. (A) PI3KC2 up-regulates Rac activity. Parental A-431 cells, and A-431 expressing
wild-type PI3KC2 and kinase-dead PI3KC2 (D1213A-17, D1213A-32) were serum-starved for 24 h and stimulated with 1 nM EGF () for
5 min. The cell lysates were equalized for protein content before immunoprecipitation with GST-PAK CRIB. Immunoprecipitated and total
Rac was detected by immunoblotting with a Rac mAb. The blots were quantified by densitometry. Data are mean with SD from four
experiments. (B–E) A-431, A-431 cells expressing wild-type or kinase-dead PI3KC2 (D1213A-17, D1213A-32) were made quiescent by
culturing in serum-free medium for 24 h before stimulation with 1 nM (C–D) or 8 nM (E) EGF for the times indicated. The Triton-soluble
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A striking phenotypic consequence of increased PI3KC2
expression was that the A-431-C2 WT cells formed more
compact colonies compared with parental A-431 cells (Sup-
plementary Figure 1B). This phenotypic change is unlikely
to be due to clonal variation as it was observed in three
independent clones. Conversely, two independent PI3KC2
D1213A-expressing lines (A-431-C2 DN-17 and DN-32) ex-
hibited a reduction in cell–cell contacts (Supplementary Fig-
ure 1C and unpublished data).
Analysis of the actin cytoskeleton of A-431-C2 WT cells
revealed that PI3KC2 expression induced an increase in
F-actin and E-cadherin at cell–cell junctions (Figure 5A),
which is in agreement with the observed effects of activated
Rac in enhancing adherens junction formation in epithelial
cells (Braga et al., 1997; Takaishi et al., 1997). Similar effects
were observed in two additional PI3KC2-expressing cell
lines, PI3KC2 Myc-4 and Glu-15 (unpublished data).
PI3KC2 showed a predominantly punctate distribution in
the cytoplasm and also localized to cell protrusions and
ruffling regions of the plasma membrane in cells at the edge
of colonies (Figure 5B, arrows), similar to the reported lo-
calization of Eps8 and Abi1 (Scita et al., 2001; Stradal et al.,
2001). The level of PI3KC2 expression varied within colo-
nies, and in the highest expressing cells there was a clear
increase in the level of polymerized actin at cell–cell junc-
tions, in the perinuclear region and in lamellipodia-like ex-
tensions. (Figure 5, A and B). The perinuclear accumulation
of F-actin may reflect a role for Rac in regulating actin
assembly on the Golgi (Fucini et al., 2002). In contrast, A-431-
C2 DN cells did not form stable adherens junctions when
subconfluent and showed an increase in the level of intra-
cellular perinuclear E-cadherin (Figure 5A). F-actin staining
Figure 4 (cont). extracts were equalized for protein content, re-
solved on duplicate gels, and probed with the indicated antibodies.
The extent of JNK, Jun, Erk, and Akt activation was assessed in the
respective cell lines by immunoblotting with phospho-specific an-
tibodies directed against the activated forms of the proteins. The
amount of total protein was established by blotting the duplicate
blots with antibodies against JNK, c-Jun, Erk, and Akt. The positions
of the bands corresponding to JNK1 (p46) and JNK2 (p54) are
indicated by arrows.
Figure 5. Effects of PI3KC2 on F-actin and
adherens junctions. (A) Growing parental
A-431 cells, A-431-C2 WT cells (WT), or
A-431-C2 DN-32 (KD) cells were fixed and
incubated with antibodies to E-cadherin fol-
lowed by FITC-labeled anti-mouse antibodies
and TRITC-labeled phalloidin to localize F-
actin. (B) Growing PI3KC2 Myc-6 cells (WT)
were fixed and stained with antibodies to the
Myc epitope to localize PI3KC2 followed by
FITC-labeled anti-mouse antibodies and
TRITC-labeled phalloidin to localize F-actin.
Arrows indicate PI3KC2 localization in la-
mellipodia. Bars (A and B), 10 m.
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of A-431-C2 DN cells revealed that cells often remained
associated via fine F-actin–containing microspikes (Figure
5A). Filopodial extension has been implicated as one of the
initial steps in adherens junction assembly (Vasioukhin et al.,
2000), where juxtaposed cells initially attach via filopodia to
promote actin polymerization and clustering of E-cadherin
at the site of cell–cell contact. It is therefore possible that
A-431-C2 DN cells retain the ability to extend filopodia, but
are unable to activate Rac in order to stabilize cell–cell
adhesion.
Because the biochemical analysis had revealed a translo-
cation of PI3KC2 to the Triton-insoluble cytoskeletal frac-
tion upon EGF stimulation (Figure 1B), we sought to further
investigate changes in PI3KC2 localization in response to
A-431 cell stimulation. Serum-starved A-431-C2 WT cells
were stimulated with EGF and localization of F-actin and
Myc-tagged PI3KC2 assessed by immunofluorescence. Co-
localization of PI3KC2 with F-actin in lamellipodia was
observed in EGF-stimulated A-431-C2 WT cells (Figure
6A, bottom panel). An enrichment of PI3KC2 was ob-
served at the leading edge of EGF-stimulated A-431-C2
WT cells, compared with serum-starved cells (Figure 6A,
top panel).
Our data had revealed an association of PI3KC2 with the
Eps8-Abi1-Sos-1 complex (Figures 1 and 2), implicated in the
regulation of Rac activity. To confirm the role of this mac-
romolecular complex in the regulation of Rac-dependent
cytoskeletal rearrangements, A-431-C2 WT cells were
transfected with an Eps8 mutant carrying a small deletion of
four amino acids (538–542) in the SH3 domain (Eps8SH3,
Myc tag). This mutant Eps8 was previously reported to be
unable to form a complex with Abi1 (Scita et al., 1999).
Staining of transfected A-431-C2 WT cells with anti-Myc
tag antibodies and phalloidin revealed a strong (60%) de-
crease of lamellipodia formation in Eps8SH3-expressing
cells (Figure 6B). Thus, perturbing the Eps8-Abi1-Sos-1 com-
plex inhibits Rac-dependent cytoskeletal rearrangements in
A-431-C2 WT cells.
We next further studied membrane ruffling in A-431 and
PI3KC2 transfectants and its dependence on Rac function.
Lamellipodia, were detected in at least 70% of EGF-treated
A-431 cells, but not (0%) in serum-starved cells (Figure 7A).
More than 60% of the PI3KC2-expressing cells displayed
lamellipodia-like extensions in the absence of EGF stimula-
tion. (Figure 7B; see also Supplementary Videos 1 and 2).
EGF-stimulated lamellipodia formation was inhibited by
transfection of RacN17 into A-431 cells (Figure 7C). More-
over, lamellipodia extension by PI3KC2-expressing cells in
serum-free medium was also inhibited by RacN17 transfec-
tion (Figure 7D). Thus PI3KC2 enhances Rac-dependent
lamellipodium formation.
PI3KC2-transfected Cells Display a Rac and
PI3K-dependent Increase in Cell Migration
Because of the reported role of Rac in regulating cell motility
(Pankov et al., 2005; Yamauchi et al., 2005), we also wanted to
investigate the effects of the PI3KC2-mediated increase in
Rac1 activation on A-431 cell migration. To this effect, A-431
and A-431-C2 WT cells were plated at 25% confluence, and
their migration pattern was followed by time-lapse micros-
copy over a period of 18 h. Cell tracks were then analyzed
using Mathematica notebooks to determine the Gaussian
distribution of migration speeds (Figure 8, A and C) as well
as the medium radius from start covered by cells in each
condition (Figure 8B). Figure 8, A and C show that PI3KC2-
tansfected cells migrated consistently faster than their pa-
rental A-431 counterparts either in the presence or absence
of EGF, a growth factor reported to increase A-431 cell
motility (Sparatore et al., 2005). We also noticed that the
RNAi-mediated down-regulation of Rac1 (Supplementary
Figure 2), had opposite effects on A-431-C2 WT and A-431
cell migration. Although the Rac siRNA increased A-431
migration speed, it counteracted the class II PI3K-mediated
increase in A-431 cell motility, reverting them to the parental
phenotype (Figure 8C). However, these changes in migra-
tion speed did not translate into an increase of the area
covered by the migrating cells as demonstrated by horizon
calculation (Figure 8B). Horizon calculation is a representa-
tion of the mean radius of the area covered by the migrating
cell from its starting point. Increase in the value of the radius
covered represents an increased persistence in cell move-
ment as opposed to randomness. Indeed, only EGF stimu-
lation allowed A-431 and A-431-C2 WT cells to migrate
further from their starting point (Figure 8B). This is also
consistent with the observation that A-431-C2 WT cells
display a fast rate of randomly forming membrane pro-
trusion with respect to A-431 cells (Figure 7, Supplemen-
Figure 6. PI3KC2 is localized to lamellipodia in EGF-stimulated
A-431 cells. (A) PI3KC2-expressing cells were incubated for 24 h in
a serum-free medium (top) or stimulated with 100 ng/ml EGF for 10
min (bottom). Cells were fixed and stained with phalloidin and
anti-Myc antibody to visualize PI3KC2. (B) A mutant of Eps8
unable to form a complex with Abi1, Eps8SH3, impairs lamel-
lipodia formation in A-431 PI3KC2-expressing cells. PI3KC2-
expressing cells were transiently transfected with myc-
Eps8SH3. After 24 h, cells were fixed and stained with anti-Myc
antibody and phalloidin. Lamellipodia, indicated by arrows,
were inhibited in roughly 60% of Eps8SH3-expressing cells.
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tary Videos 1 and 2). These data suggest that although
PI3KC2 overexpression provides A-431 cells with in-
creased motility speeds, it does not allow for migratory
directional persistence. In support of this notion, the mi-
gration speed of A-431 cells expressing dominant negative
PI3KC2 was significantly decreased, compared with
wild-type A-431 cells (Figure 8D). Moreover, the area
covered by migrating A-431-C2 DN cells was reduced,
compared with control A-431 cells (Figure 8E). Thus,
PI3KC2 catalytic activity is also required for migratory
directional persistence.
PI3KC2 Expression Increases Cell Proliferation and
Renders A-431 Cells Resistant to Anoikis
We next investigated whether the differences in activation of
early signaling events observed between A-431 and PI3KC2-
transfected cells (Figure 4) correlated with changes in pro-
liferation and survival of the cells. Proliferation of A-431-
C2 WT cells was elevated by 1.75-fold, as compared with
A-431 cells (Figure 9A). This difference was observed both
in medium containing low (1%) or high (10%) serum
(unpublished data). To investigate whether the increased
proliferation of A-431-C2 WT was dependent on the
function of JNK or Akt, pharmacological inhibitors of
both kinases were tested on both A-431 and A-431-C2
WT cells. The Akt inhibitor (1L-6-hydroxymethyl-chiro-ino-
sitol 2-(R)-2-O-methyl-3-O-octadecylcarbonate) failed to re-
duce the difference in proliferation between both cell lines at
concentrations up to 20 M (unpublished data). At these
concentrations, however, it completely inhibited growth of
human neuroblastoma cell lines (unpublished data). A cell-
permeable peptide inhibitor of JNK translocation (reported
IC50  1 M for JNK inhibition) also did not reduce the
proliferation of either cell line, although at high concentra-
tions (25 M) it reduced proliferation of A-431-C2 WT
cells (Figure 9B).
Anoikis is a form of cell death induced by cell detachment
from the underlying substratum. Resistance to anoikis is re-
Figure 7. PI3KC2 expression induces la-
mellipodia constitutively in a Rac-dependent
manner. Serum-deprived A-431 control (A) or
A-431 PI3KC2-expressing cells (Myc 6; B)
were stimulated with 100 ng/ml EGF for 10
min (right panels) or left untreated (left panels),
fixed, and stained with phalloidin to detect F-
actin. (C) A-431 control cells were transiently
transfected with HA-RacN17, serum-starved,
and stimulated with 100 ng/ml EGF. Cells
were fixed and stained with anti-HA antibod-
ies and phalloidin. Lamellipodia, indicated by
arrows, are inhibited in all RacN17-expressing
cells. (D) PI3KC2-expressing A-431 cells (Myc 6)
were transiently transfected with HA-RacN17.
Cells were then fixed and stained as in C.
Lamellipodia extensions, indicated by arrows,
were inhibited in 100% of RacN17-expressing
cells.
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quired for tumor cells to establish remote metastasis (Liotta
and Kohn, 2004). Therefore, experiments were conducted to
investigate whether PI3KC2 expression modified the sur-
vival of A-431 cells. A-431 and PI3KC2-transfected cells
were allowed to keep in suspension by plating on ultralow
attachment dishes. After 12-h incubation at 37°C, the cells
were fixed and stained by propidium iodide for flow cytom-
etry analysis of DNA content. The proportion of dead cells
was measured by detecting cells in the sub-G1 fraction of the
DNA profile. Figure 9C shows that the proportion of cells in
sub-G1 was twice as high in A-431 as in A-431-C2 WT cells
(30% vs. 15%). This difference maintained even at 24-h
after detachment (Figure 9D), showing that PI3KC2 expres-
sion provides A-431 cells with a long-lasting protection from
cell death. In both cell lines, addition of EGF inhibited the
induction of anoikis (Figure 9, C and D), as previously
described (Jost et al., 2001; Reginato et al., 2003). This de-
crease in the proportion of cells in sub-G1 correlated with an
inhibition of phosphatidylserine exposure in PI3KC2-trans-
fected cells as demonstrated after Annexin V staining (Fig-
ure 9E). Taken together these results demonstrate that ex-
pression of class II PI3K desensitizes A-431 cells to the
induction of anoikis.
Rac1 and E-Cadherin Do Not Mediate the Resistance of
PI3KC2-transfected Cells to Anoikis
Our previous data had revealed that PI3KC2-transfected
cells display an increase in Rac1 activation and E-cadherin
levels (Figures 4 and 5). As these two proteins have been
linked to cell survival in other cell systems (Murga et al.,
2002; Ferreira et al., 2005), we investigated the possibility
that they might participate to Myc6 cells resistance to
anoikis. However, down-regulation of Rac1 using oligonu-
cleotide RNAi (Supplementary Figure 2C) had no effect on
either A-431-C2 WT or A-431 cell survival after cell detach-
ment (Supplementary Figure 2A). Similarly, E-cadherin in-
hibition using neutralizing antibodies, although decreasing
cell–cell contacts in A-431-C2 WT cells back to the extent
Figure 8. Rac1 RNAi differentially affect A-431
and A-431-C2 WT cell migration. (A and B)
A-431 and A-431-C2 WT cells (Myc 6) cells
were treated with or without EGF. (C) A-431
and A-431-C2 WT cells were transfected with
Rac1 RNAi or scrambled control () and left for
48 h in culture to achieve target down-regula-
tion. Cell migration tracks were monitored by
live microscopy for 18 h, and migration speed
(A and C) or horizon radius (B) was determined
using Mathematica. These results are represen-
tative of a minimum of three independent ex-
periments. Each condition was performed in
quadruplicate using 15 cells per replicate. (D
and E) Cell migration tracks of A-431 cells, or
A-431 expressing kinase-dead PI3KC2 (C2
DN-17, C2 DN-32) were monitored by live
microscopy for 18 h, and migration speed (D),
or track paths (E) were determined using Math-
ematica. Results are representative of a mini-
mum of three independent experiments. Each
condition was performed in quadruplicate us-
ing 15 cells per replicate. (Significant difference
as compared with control A-431 (A and D) or
between Rac1 RNAi and scrambled control (C);
Student’s t test: *p 	 0.05; **p 	 0.01; ***p 	
0.001).
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observed in A-431 cells (Supplementary Figure 2D), did not
impair A-431-C2 WT cells’ ability to resist anoikis (Supple-
mentary Figure 2B). Therefore, neither Rac1 nor E-cadherin
appear to contribute to the difference in sensitivity to anoikis
that exist between A-431 and A-431-C2 WT cells.
Detachment-induced Changes in Early Signaling
Molecules Activation and Sensitivity to Anoikis of A-431
and PI3KC2-transfected Cells
We then hypothesized that differences in the activation of
early signaling molecules might be involved in the inhibi-
Figure 9. PI3KC2-transfected A-431 cells display enhanced proliferation and are resistant to anoikis. (A and B) A-431 and A-431-C2 WT
(Myc 6) cells were incubated for 72 h in medium containing 1% serum in the absence (A) or presence (B) of increasing concentrations of a
cell-permeable JNK inhibitor peptide. Cell proliferation was assessed using a MTS assay. Data are mean with SD from eight repetitions. (C–E)
A-431 and A-431-C2 WT (Myc 6) cells were placed for 12 h (C–E) or 24 h (D) in anchorage-free conditions in the presence or absence of EGF.
Cells were then stained using propidium iodide alone (C and D) or in conjunction with annexin V (E) and the proportion of cells in SubG1
(C and D) or positive for annexin V only (E) determined by flow cytometry.
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tion of anoikis after expression of the class-II PI3K. Hence,
we determined the phosphorylation status of Erk, Akt, p38,
and JNK in A-431 and A-431-C2 WT cells both while at-
tached and 6 h after detachment.
The phosphorylation of p38 appeared unmodified by cell
detachment (Supplementary Figure 2E) and incubation of
A-431 or A-431-C2 WT cells with the p38 inhibitor, SB202190,
although increasing to the same extent the baseline cell
death level for both cell lines, did not counteract the effects
of class II expression on A-431 survival to anoikis. This
suggest that p38 is not involved in the survival advantage of
A-431-C2 WT cells.
Although phosphorylation of Erk was equal in attached
A-431 and Myc6 cells and remained identical in A-431-C2
WT cells upon detachment, the amount of activated Erk
decreased noticeably in A-431 cells after 6 h in anchorage-
free incubation (Supplementary Figure 2E). However, inhi-
bition of mitogen-activated Erk kinase (MEK) in A-431-C2
WT cells using PD098059 did not prevent the inhibition of
cell death observed in these cells upon detachment (Supple-
mentary Figure 2F). This would suggest that differences in
the activation of the MEK/Erk pathway between A-431 and
A-431-C2 WT cells are not responsible for their differences
in survival.
The phosphorylation of Akt increased in both A-431 and
Myc6 cells upon detachment (Supplementary Figure 2E).
Although the extent of this increase was similar in the two
cell lines, the effects of Akt phosphorylation might still be
differentially regulated in A-431 and A-431-C2 WT cells by
downstream effectors of Akt. However, Supplementary Fig-
ure 2G demonstrates that RNAi-mediated down-regulation
of Akt1 and 2 (Supplementary Figure 2C), in isolation or
jointly, while increasing the level of cell death in both cell
lines, did not prevent the prosurvival advantage of class II
PI3K overexpression in A-431-C2 WT cells (Supplementary
Figure 2G). Also, the inhibition of the downstream effector
of Akt, mTOR (the mammalian target of rapamycin) by
rapamycin, did not abolish the survival differential between
A-431 and A-431-C2 WT cells (Supplementary Figure 2G).
This suggests that changes in Akt phosphorylation cannot
account for the class II–mediated inhibition of anoikis.
In contrast to activated Akt levels, the basal phosphory-
lation of JNK decreased sharply following detachment, both
in A-431 and A-431-C2 WT cells (unpublished data). In
addition, we found that down-regulation of the JNK up-
stream kinase, MKK7, by RNAi (Supplementary Figure 2C),
while greatly increasing the death toll upon detachment of
A-431 cells, had no similar effect on A-431-C2 WT cells
survival (Supplementary Figure 2H).
DISCUSSION
The search for potential regulators or effectors of PI3KC2
signaling has identified Abi1, Eps8, and Sos as novel inter-
action partners of PI3KC2. Our results show that PI3KC2
forms a complex with Eps8-Abi1-Sos1 upon EGF stimulation
and that it regulates Rac activity. Class II PI3Ks preferen-
tially generate PI(3)P and PI(3,4)P2 in vitro (Arcaro et al.,
1998, 2000), but will generate PI(3,4,5)P3 under certain con-
ditions (Gaidarov et al., 2001), and thus have the potential to
generate the same spectrum of 3
-phosphoinositides as class
I PI3Ks. We propose that one way through which PI3KC2
can activate Rac by producing phosphoinositides that acti-
vate Sos-1 Rac GEF activity in the PI3KC2-Eps8-Abi1-Sos1
complex. Rac then controls membrane ruffling, cell motility,
and cadherin-mediated cell–cell adhesion. Our data suggest
that the major determinant in mediating an EGFR-PI3KC2-
Grb2-Eps8 complex is Grb2. Within this macromolecular
unit, however, multiple surfaces of interaction are likely to
stabilize the entire signaling unit. The PI3KC2-Grb2-Abi1-
Eps8-Sos1 complex could interact with the activated EGFR-1
either directly (pY1068) or indirectly (pY992) through com-
plex formation with Shc. Interestingly, an interaction be-
tween the tyrosine phosphorylated p66Shc isoform with
PI3KC2 was found specifically in the Triton-insoluble cy-
toskeletal fraction of EGF-stimulated A-431 cells. This obser-
vation may reflect a selective role for PI3KC2 and p66Shc in
transducing signals controlling cytoskeletal rearrangements,
because a recent report has shown that this Shc isoform
plays a role Sos-mediated activation of Rac1 (Khanday et al.,
2006). EGFR-1 regulates this macro-molecular complex by
stimulating PI3KC2 lipid kinase activity in the complex. In-
terestingly, a Shc-Grb2-Gab ternary complex has been shown
to recruit class I PI3Ks to activated EGFR-1 (Rodrigues et al.,
2000), implying that there might be two distinct Shc-Grb2-PI3K
class I and II complexes downstream of EGFR-1.
As A-431 cells produce and are constitutively activated by
TGF- acting on the EGFR-1 (Van de Vijver et al., 1991; Jo et
al., 2000), it is likely that this induces sufficient PI3KC2
activation in PI3KC2-overexpressing cells to transduce sig-
nals to Rac, without addition of EGF. Indeed, PI3KC2 trans-
fection constitutively stimulated membrane ruffling and cell
motility, and both responses were impaired by dominant neg-
ative Rac or RNAi. EGF can promote motility and invasion
of A-431 cells (Malliri et al., 1998), but is likely that other
signals in addition to Rac activation are required for this
response, as is the case in HGF-stimulated MDCK cells
(Potempa and Ridley, 1998; Sander et al., 1998). Indeed,
down-regulation of Rac by RNAi had opposite effects on
A-431 and A-431-C2 WT cells, enhancing the migration
speed of the parental cells, while inhibiting the response of
the transfectants. A possible model is that in A-431 cells Rac1
predominantly controls cell–cell contacts and thus functions
as a negative regulator of cell motility. Interestingly, down-
regulation of the Rac exchange factor Tiam1 was shown to
induce disassembly of cadherin-based adhesions, resulting
in enhanced migration of MDCK cells (Malliri et al., 2004). In
contrast, in A-431-C2 WT cells, where Rac1 is constitutively
activated, it may function predominantly as a regulator of
cell motility and membrane ruffling.
PI3K has been implicated in the regulation of E-cadherin–
mediated adherens junction assembly in a number of inde-
pendent studies (Nakagawa et al., 2001; Kovacs et al., 2002).
However, these studies have used the generic PI3K inhibi-
tors, wortmannin and LY294002, which do not discriminate
between class I and class II PI3K-regulated events. Gene
targeting studies have recently revealed a specific role for
class IA PI3K isoforms in cytoskeletal rearrangements, such
as membrane ruffling stimulated by PDGF (Brachmann et al.,
2005). The relative contribution of class II or class I PI3Ks to
Rac activation is thus likely to depend on the receptor uti-
lized as well as the cellular context. Previous work has
shown that the EGF receptor couples to class IA PI3K sig-
naling only in a cell type–specific manner (Arcaro et al.,
2000). Sos-1 can contribute to Rac activation both directly,
through its Rac GEF domain and indirectly through activa-
tion of Ras by its Ras GEF domain and subsequent PI3K
activation (Rodriguez-Viciana et al., 1997). We have previ-
ously shown that in contrast to class I PI3Ks, PI3KC2 is not
activated by Ras (Arcaro et al., 1998). Therefore, although
class I PI3Ks mediate Ras-dependent activation of Rac,
PI3KC2 is likely to couple growth factor receptor signals to
the Rac machinery in a Ras-independent manner. Although
more work will be required to define the exact interplay of
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the respective components, it is feasible that the divergent
influence of Ras regulation of classes I and II PI3Ks upstream
of Rac will also influence the cellular outcome. In conclu-
sion, our results identify novel effectors of PI3KC2 cellular
function and demonstrate for the first time a role for a class
II PI3K in cytoskeletal activation by defining a molecular
link between the EGFR-1, PI3KC2, and Rac. A recent report
has shown that PI3KC2 controls cell migration in response
to lysophosphatidic acid (LPA) in human cancer cells such
as HeLa cells (Maffucci et al., 2005). It is at present unclear
whether the same molecular mechanisms are involved in the
ability of PI3KC2 to transduce signals from serpentine
(LPA) or receptor tyrosine kinases (EGFR), although LPA is
a known activator of Rac (Moolenaar et al., 2004).
In contrast to its role in the regulation of cell motility
and membrane ruffling, Rac1 appeared to play no role in
PI3KC2-induced protection of A431 from anoikis. The anti-
apoptotic effect of PI3KC2 overexpression was also inde-
pendent of Akt signaling, mTOR, and E-cadherin–mediated
cell–cell contact. The observation that PI3KC2-transfected
cells display enhanced growth may thus be in part a result of
this difference in survival. In agreement with the anoikis
data, pharmacological inhibitors of JNK or Akt failed to
affect the enhanced growth response observed in PI3KC2-
overexpressing A-431 cells. Pharmacological inhibition of
MEK also failed to alter the response, but PI3KC2-trans-
fected A-431 cells displayed a more sustained activation of
Erk1/2 than A-431 cells upon detachment. Thus, one cannot
exclude the possibility that the differences in Erk activity
between the two cell lines occur via a MEK-independent
pathway (for example, protein kinase C [PKC] isoforms,
phophatases; Grammer and Blenis, 1997; Bapat et al., 2001;
Kinkl et al., 2001; Tajima et al., 2005). EGF-stimulated activa-
tion of JNK was enhanced in PI3KC2-transfected cells,
correlating with the increase in Rac1 activation in these cells.
Moreover, our data show that down-regulation of the JNK
upstream kinase, MKK7 by RNAi, while greatly increasing
detachment-induced apoptosis of A-431 cells, had no similar
effect on A-431-C2 WT cells’ survival. In line with the
reported role of the JNK pathway in the survival of some cell
systems (Wang et al., 1999; Gururajan et al., 2005), these data
suggest that inhibition of JNK activity is toxic to A-431 cells
and that class II overexpression might prevent this toxicity
in A-431-C2 WT cells.
Although the present study was restricted to the A-431
cell line, we have found evidence that PI3KC2 interacts
with Eps8 and regulates Rac activity in other human cancer
cell lines. In human small cell lung cancer (SCLC) cell lines,
which overexpress PI3KC2, compared with normal lung
epithelial cells (Arcaro et al., 2002), an interaction between
Eps8 and the class II PI3K was observed. SCLC cell lines
expressing high levels of endogenous PI3KC2 had in-
creased Rac activity and displayed enhanced JNK activation,
compared with cell lines with low levels of PI3KC2 expres-
sion. Moreover, expression of kinase dead PI3KC2 in SCLC
cells inhibited Rac and JNK activation (unpublished obser-
vations). Thus, the interaction of PI3KC2 with Eps8 in-
volved in Rac activation may be of significance in various
human cancer cells.
Together, the present report provides novel insights into
the functions of class II PI3Ks in the context of human
cancer. Human tumor cells have been reported to overex-
press class II PI3K isoforms, such as PI3KC2 (Arcaro et al.,
2002). The ability of PI3KC2 to enhance migration and
protect cells from anoikis may provide a crucial contribution
to the malignant phenotype of various human cancers.
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